Cargando…
A bispecific chimeric antigen receptor molecule enhances T cell activation through dual immunological synapse formation and offsets antigen escape in glioblastoma
Autores principales: | Hegde, Meenakshi, Grada, Zakaria, Pignata, Antonella, Wakefield, Amanda, Fousek, Kristen, Bielamowicz, Kevin, Chow, Kevin, Brawley, Vita, Byrd, Tiara, Gottschalk, Stephen, Mukherjee, Malini, Wels, Winfried S, Baker, Matthew, Dotti, Giapietro, Orange, Jordan, Ahmed, Nabil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645273/ http://dx.doi.org/10.1186/2051-1426-3-S2-O3 |
Ejemplares similares
-
TanCAR: A Novel Bispecific Chimeric Antigen Receptor for Cancer Immunotherapy
por: Grada, Zakaria, et al.
Publicado: (2013) -
Dual targeting of the tumor and its associated vasculature using a single bispecific chimeric antigen receptor molecule
por: Byrd, Tiara, et al.
Publicado: (2014) -
Combinational Targeting Offsets Antigen Escape and Enhances Effector Functions of Adoptively Transferred T Cells in Glioblastoma
por: Hegde, Meenakshi, et al.
Publicado: (2013) -
Autologous HER2 CMV bispecific CAR T cells are safe and demonstrate clinical benefit for glioblastoma in a Phase I trial.
por: Ahmed, Nabil, et al.
Publicado: (2015) -
TEM8 specific T cells target the tumor cells and tumor-associated vasculature in triple negative breast cancer
por: Byrd, Tiara, et al.
Publicado: (2014)